Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03831191

Public ClinicalTrials.gov record NCT03831191. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3375880 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis: The ADmIRe Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The reason for this study is to see if the study drug LY3375880 is safe and effective in adults with moderate-to-severe atopic dermatitis (AD).

Study identification

NCT ID
NCT03831191
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
136 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 12, 2019 (Actual)
Primary completion
Feb 27, 2020 (Actual)
Completion
Feb 27, 2020 (Actual)
Last update posted
Apr 20, 2021

2019 – 2020

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Tien Q. Nguyen, MD inc. DBA First OC Dermatology Fountain Valley California 92708 —
Dermatology Research Associates Los Angeles California 90045 —
Quest Dermatology Research Northridge California 91324 —
Integrative Skin Science and Research Sacramento California 95815 —
Arlington Dermatology Rolling Meadows Illinois 60008 —
The South Bend Clinic South Bend Indiana 46617 —
Dermatology and Skin Cancer Specialists Rockville Maryland 20850 —
ActivMed Practices & Research, Inc Portsmouth New Hampshire 03801 —
Piedmont Plastic Surgery and Dermatology Charlotte North Carolina 28277 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28411 —
Hightower Clinical Trial Services Norman Oklahoma 73072 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
Clinical Partners LLC Johnston Rhode Island 02919 —
Center for Clinical Studies Houston Texas 77004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03831191, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03831191 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →